LEO Pharma and Veeva Systems Partner for Patient-centric Digital Trials

LEO Pharma and Veeva Systems have announced a strategic technology partnership to enable scalable digital trials that are patient-centric and paperless. LEO Pharma will utilize the integrated suite of Veeva clinical products, including eTMF, CTMS, CDMS, Site Connect, eConsent, ePRO, Virtual Visits, and eSource.

By adopting technology and business processes, LEO Pharma hopes to achieve the following:

  • Significantly improved patient experience
  • Increased patient diversity through decentralized trials
  • Higher accuracy in clinical data
  • 25% reduction in clinical trial cost
  • 25% reduction in clinical trial time

More on LEO Pharma and Veeva Systems partnership